J. I. Silverberg, N. Kragh, E. Guttman-Yassky, and A. Wollenberg, “Treatment with tralokinumab improves health-related quality of life in adult patients with moderate to severe atopic dermatitis: results from a Phase 2b, randomised, double-blind, placebo-controlled study”, J of Skin, vol. 2, p. S64, Dec. 2018.